“Perioperative immune checkpoint inhibitors plus chemotherapy versus chemotherapy alone in resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis”, Nepal J Epidemiology, vol. 16, no. 1, pp. 1412–1423, Apr. 2026, doi: 10.3126/nje.v16i1.92321.